Rhizopus stolonifer mediated biosynthesis of biocompatible cadmium chalcogenide quantum dots

• Published in: Enzyme and microbial technology 2016-12, Vol.95, p.225-229
• Main Authors: Mareeswari, P., Brijitta, J., Harikrishna Etti, S., Meganathan, C., Kaliaraj, Gobi Saravanan
• Format: Article
• Language: English
• Subjects: Animals; Biosynthesis; Biotechnology; Cadmium Compounds - chemistry; Cadmium Compounds - metabolism; Chalcogens - chemistry; Chalcogens - metabolism; Cytotoxicity; Green Chemistry Technology; Humans; MCF-7 Cells; Mice; Nanotechnology; NIH 3T3 Cells; Photoluminescence; Quantum dots; Quantum Dots - chemistry; Quantum Dots - metabolism; Quantum Dots - ultrastructure; Rhizopus - metabolism; Sulfides - chemistry; Sulfides - metabolism; Tellurium - chemistry; Tellurium - metabolism; XRD
• ISSN: 0141-0229; 1879-0909
• DOI: 10.1016/j.enzmictec.2016.08.016

We report an efficient method to biosynthesize biocompatible cadmium telluride and cadmium sulphide quantum dots from the fungus Rhizopus stolonifer. The suspension of the quantum dots exhibited purple and greenish-blue luminescence respectively upon UV light illumination. Photoluminescence spectroscopy, X-ray diffraction, and transmission electron microscopy confirms the formation of the quantum dots. From the photoluminescence spectrum the emission maxima is found to be 424 and 476nm respectively. The X-ray diffraction of the quantum dots matches with results reported in literature. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay for cell viability evaluation carried out on 3-days transfer, inoculum 3×105 cells, embryonic fibroblast cells lines shows that more than 80% of the cells are viable even after 48h, indicating the biocompatible nature of the quantum dots. A good contrast in imaging has been obtained upon incorporating the quantum dots in human breast adenocarcinoma Michigan Cancer Foundation-7 cell lines.